Woodline Partners’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-133,406
| Closed | -$113K | – | 1045 |
|
|
2025
Q4 | $113K | Sell |
133,406
-32,234
| -19% | -$41.7K | ﹤0.01% | 1009 |
|
|
2025
Q3 | $275K | Hold |
165,640
| – | – | ﹤0.01% | 858 |
|
|
2025
Q2 | $195K | Buy |
165,640
+1,275
| +0.8% | +$2.34K | ﹤0.01% | 904 |
|
|
2025
Q1 | $355K | Buy |
164,365
+64,675
| +65% | +$158K | ﹤0.01% | 849 |
|
|
2024
Q4 | $282K | Buy |
99,690
+69,158
| +227% | +$328K | ﹤0.01% | 893 |
|
|
2024
Q3 | $188K | Buy |
+30,532
| New | +$197K | ﹤0.01% | 578 |
|
